| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5125545 | B | Inhibition of SETD2 (1434 to 1711 residues) (unknown origin) using SAM and biotin-Ahx-RKSAPATGGVKKPHR-NH2 as substrate preincubated for 30 mins followed by substrate addition by topcount scintillation counting method | Homo sapiens | 10 | single protein format | Scientific Literature | ||
| 2. | ALA5125546 | B | Inhibition of SETD2 in human A549 cells assessed as reduction in H3K36me3 incubated for 3 days by in-cell western assay | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 3. | ALA5125547 | F | Antiproliferative activity against human KMS-34 cells assessed as reduction in cell viability incubated for 14 days by CellTiter-glo luminescence assay | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 4. | ALA5125548 | A | Apparent permeability across apical to basal side in human Caco-2 cells at 5 uM measured after 2 hrs by LC-MS/MS analysis | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 5. | ALA5125549 | A | Apparent permeability across basal to apical side in human Caco-2 cells at 5 uM measured after 2 hrs by LC-MS/MS analysis | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 6. | ALA5125550 | A | Stability in human hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 120 mins by LC/MS/MS analysis | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 7. | ALA5125551 | A | Stability in rat hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 60 mins by LC/MS/MS analysis | Rattus norvegicus | 6 | cell-based format | Scientific Literature | ||
| 8. | ALA5125552 | A | Stability in mouse hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 60 mins by LC/MS/MS analysis | Mus musculus | 6 | cell-based format | Scientific Literature | ||
| 9. | ALA5125570 | A | Clearance in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA5125571 | A | Volume of distribution at steady state in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 11. | ALA5125572 | A | AUC in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA5125573 | A | Half life in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 13. | ALA5125578 | A | Cmax in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 14. | ALA5125579 | A | AUC in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 15. | ALA5125580 | A | Half life in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 16. | ALA5125581 | A | Oral bioavailability in CD-1 IGS mouse at 50 mg/kg by LC-MS/MS analysis | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 17. | ALA5125582 | A | Clearance in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA5125583 | A | Volume of distribution in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 19. | ALA5125584 | A | AUC in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
| 20. | ALA5125585 | A | Half life in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis | Rattus norvegicus | 2 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!